Price $81.44 |
Market Cap
4.18B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
57.3
|
P/B
3.69
|
P/S
3.67
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
61.6
|
Op. Cash Flow
114.3K
|
FCF
1.2
|
|
Op. Margin
7.60%
|
Net Margin
6.50%
|
ROE
6.80%
|
ROI
5.90%
|
|
ROA
4.50%
|
EPS Growth
52.00%
|
Current Ratio
2.4
|
Debt/Equity
16.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Puma Biotechnology Inc (PBYI) | $3.27 | - | - | 133.9M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $8.19 | - | - | 2.78B | Strong Buy |
| Baudax Bio Inc (BXRX) | $0.52 | - | - | 4.4M | Strong Buy |
| Eton Pharmaceuticals Inc (ETON) | $3.86 | - | - | 101.3M | Strong Buy |
| Spero Therapeutics Inc (SPRO) | $1.77 | - | - | 74.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
